Fertility Supplements Market Size, Share, Growth Analysis, By End-Use(Men, and Women), By Distribution Channel(OTC, and Prescribed) - Industry Forecast 2024-2031


Report ID: SQMIG30I2247 | Region: Global | Published Date: April, 2024
Pages: 198 | Tables: 61 | Figures: 75

To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
$5,300
BUY NOW
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Fertility Supplements Market size was valued at USD 1.94 Billion in 2022 and is poised to grow from USD 2.10 Billion in 2023 to USD 3.88 Billion by 2031, at a CAGR of 8% during the forecast period (2024-2031).

The fertility supplements market is highly competitive in nature with the presence of various key players. The market is fragmented due to the presence of numerous local and international players, and the high degree of competition is leading to continuous innovation, development, and launching of new products. The competitive landscape of the fertility supplements market is expected to remain intense, with companies focusing on product innovation, strategic partnerships, and mergers and acquisitions to gain a competitive advantage. 'TTK HealthCare (India)', 'Fairhaven Health LLC (U.S.)', 'Zenith Nutritions (India)', 'INVO Bioscience (U.S.)', 'Vitabiotics Ltd (U.K.)', 'Bionova Lifesciences (India)', 'Exeltis USA Inc. (U.S.)', 'Fujifilm Irvine Scientific, Inc. (U.S.)', 'Coast Science (U.S.)', 'Orthomol (Germany)', 'Theralogix LLC (U.S.)', 'Mira (U.S.)', 'Proxeed Plus (U.S.)', 'Fertility Nutraceuticals LLC (U.S.)', 'Fertility Focus Limited (U.K.)', 'DCC plc (Ireland)', 'Purelife Bioscience Co. Ltd. (Taiwan)', 'Fertility Smart (Australia)', 'Concepta Diagnostics (U.K.)', 'TTK Prestige Ltd (India)'

The rising prevalence of infertility among both men and women is a key driver of the fertility supplements market. As per data from the CDC, infertility affects around 15% of couples globally, and the rate is increasing. This has led to a surge in demand for fertility supplements as they offer a non-invasive and cost-effective alternative to conventional fertility treatments.

Increasing demand for natural and organic supplements: Consumers are increasingly opting for natural and organic fertility supplements as they are perceived to be safer and have fewer side effects. These supplements are made from natural ingredients such as herbs, vitamins, and minerals, and do not contain any synthetic substances. For instance, In folic, a natural supplement made from myo-inositol and folic acid, has gained popularity in the market due to its natural composition and effectiveness in promoting fertility.

North America held the largest share in the fertility supplements market. Data from the Centers for Disease Control and Prevention (CDC) update indicated that 14.1% of women aged 15 to 49 in the U.S. had impaired fertility, while 15.1% of married women aged 15 to 49 had impaired fertility. In addition, 7% of married women were found to be infertile, which has increased the demand for fertility products in the region. Furthermore, the market in Canada is expected to grow rapidly due to initiatives by the government and nonprofit organizations such as Fertility Matters Canada to raise awareness about fertility medication and treatment, as well as the rising rates of obesity and sexually transmitted infections.

Feedback From Our Clients

Global Fertility Supplements Market

Product ID: SQMIG30I2247

$5,300
BUY NOW